Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

View source ↗

Summary

An ongoing Pfizer-sponsored real-world study in Australia is evaluating how effective the maternal RSVpreF vaccine is at preventing respiratory syncytial virus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSVpreF vaccine (RSV prefusion F vaccine)

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus | Status: ACTIVE_NOT_RECRUITING